Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 05 2021
Historique:
received: 11 01 2021
accepted: 26 04 2021
entrez: 13 5 2021
pubmed: 14 5 2021
medline: 25 2 2023
Statut: epublish

Résumé

This study aimed to evaluate the predictions of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for prognosis of triple-negative breast cancer (TNBC), especially with residual disease (RD) after preoperative chemotherapy. This retrospective analysis included 74 TNBC patients who received preoperative chemotherapy. DCE-MRI findings from three timepoints were examined: at diagnosis (MRI

Identifiants

pubmed: 33980938
doi: 10.1038/s41598-021-89380-4
pii: 10.1038/s41598-021-89380-4
pmc: PMC8115642
doi:

Substances chimiques

Antineoplastic Agents 0
Contrast Media 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10112

Références

Springerplus. 2016 Feb 24;5:152
pubmed: 27026849
J Clin Oncol. 2013 Oct 10;31(29):3623-30
pubmed: 24002511
Acta Oncol. 2007;46(7):996-1003
pubmed: 17851879
Eur J Radiol. 2012 Sep;81(9):2148-53
pubmed: 21664779
Eur J Radiol. 2009 Sep;71(3):498-505
pubmed: 18572340
J Clin Oncol. 2017 Apr 1;35(10):1049-1060
pubmed: 28135148
Clin Radiol. 2018 Aug;73(8):700-714
pubmed: 29229179
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Radiology. 2012 Jun;263(3):663-72
pubmed: 22623692
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Oncol Lett. 2013 Jan;5(1):83-89
pubmed: 23255899
Breast J. 2017 Nov;23(6):656-662
pubmed: 28397346
Eur J Radiol. 2014 Sep;83(9):1631-8
pubmed: 24938669
Ann Oncol. 2017 Oct 1;28(10):2420-2428
pubmed: 28961844
J Natl Cancer Inst. 2008 Apr 16;100(8):542-51
pubmed: 18398097
J Surg Oncol. 2007 Nov 1;96(6):474-80
pubmed: 17640031
J Clin Oncol. 2007 Oct 1;25(28):4414-22
pubmed: 17785706
Cancer. 2013 May 15;119(10):1776-83
pubmed: 23436342
Clin Transl Oncol. 2012 Jun;14(6):486-8
pubmed: 22634539
Lancet. 2014 Jul 12;384(9938):164-72
pubmed: 24529560
Radiol Bras. 2019 Sep-Oct;52(5):299-304
pubmed: 31656346
Radiology. 2016 Apr;279(1):44-55
pubmed: 26624971
Eur J Radiol. 2019 Sep;118:285-292
pubmed: 31324411
AJR Am J Roentgenol. 2019 Oct;213(4):944-952
pubmed: 31237439
J Clin Oncol. 2008 Mar 10;26(8):1275-81
pubmed: 18250347
Eur J Radiol. 2012 Oct;81(10):2627-31
pubmed: 22221829
Clin Cancer Res. 2016 Jan 1;22(1):26-33
pubmed: 26286912

Auteurs

Ayane Yamaguchi (A)

Department of Breast Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.

Maya Honda (M)

Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Hiroshi Ishiguro (H)

Breast Oncology Service, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, 350-1298, Japan.

Masako Kataoka (M)

Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Tatsuki R Kataoka (TR)

Department of Molecular Diagnostic Pathology, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate Prefecture, 028-3694, Japan.

Hanako Shimizu (H)

Department of Breast Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.

Masae Torii (M)

Department of Breast Surgery, Japanese Red Cross Wakayama Medical Center, 4-20 Komatsubara-dori, Wakayama, 640-8558, Japan.

Yukiko Mori (Y)

Department of Therapeutic Oncology, Kyoto University Hospital, 54 Shogoin kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Nobuko Kawaguchi-Sakita (N)

Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Kentaro Ueno (K)

Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 54 Shogoin kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Masahiro Kawashima (M)

Department of Breast Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.

Masahiro Takada (M)

Department of Breast Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.

Eiji Suzuki (E)

Department of Breast Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.

Yuji Nakamoto (Y)

Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Kosuke Kawaguchi (K)

Department of Breast Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan. kkosuke@kuhp.kyoto-u.ac.jp.

Masakazu Toi (M)

Department of Breast Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH